Marker Therapeutics, Inc. (MRKR) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-05-04 | 8-K | Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-03-19 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-09 | 8-K | Item 5.08, Financial Statements & Exhibits | SEC |
| 2025-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Officer / Director Changes, Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-26 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-12 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-06-17 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-09 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-31 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-27 | 8-K | Shareholder Vote Results | SEC |
| 2025-02-19 | 8-K | Officer / Director Changes, Other Events | SEC |
| 2025-01-30 | 8-K | Officer / Director Changes | SEC |
| 2024-12-23 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-12-19 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-17 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-12 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-12 | 8-K | Shareholder Vote Results, Other Events | SEC |
| 2024-05-15 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-26 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-01 | 8-K | Termination of Agreement | SEC |
| 2024-02-26 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-01-08 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.